A retrospective cohort analysis of bedaquiline resistance in patients with Rifampicin Resistant TB with or without second line drug resistance, Karakalpakstan (2015-2020)

Principal investigator

Location

Uzbekistan
Topics

AMR, Tuberculosis
Methodology

Observational study
Reference

OCA020-56
Views

78
Downloaded

4

Purpose of study

The study will evaluate the risk factors associated with amplification of resistance in patients with RR-TB and on new drugs within a long running large comprehensive TB programme.

Study status

Concept
Protocol & ERB
Implementation
Completion
Archived

Study timeline

Documents

803-conference-abstract-2022-11-08.pptx 7.36 MB
Concept_note_ND_resistance_updated_11.08.2020.docx 57.1 KB
MSF_RC_feedback_on_CN_new_drug_resistance_Uzbekistan.docx 22.2 KB

Publications

Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

Nair, P. "–" International Union Against Tuberculosis and Lung Disease "(2022)"
Primary bedaquiline resistance in Karakalpakstan, Uzbekistan

Moe, S. "–" International Union Against Tuberculosis and Lung Disease "(2023)"

Previous study

Next study